| Daniel James Link, PHARMD | |
|
950 N Lake Blvd, Tahoe City, CA 96145-9800 | |
| (530) 584-0250 | |
| (530) 584-0255 |
| Full Name | Daniel James Link |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 950 N Lake Blvd, Tahoe City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457825812 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 71474 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel James Link, PHARMD 950 N Lake Blvd, Tahoe City, CA 96145-9800 Ph: (530) 584-0250 | Daniel James Link, PHARMD 950 N Lake Blvd, Tahoe City, CA 96145-9800 Ph: (530) 584-0250 |
News Archive
Rhode Island's legislature currently is considering a bill (H.B. 5415) that would eliminate a requirement that a person sign his or her name before undergoing an HIV test, which "would essentially make getting an HIV test more like getting any other medical test," Brian Alverson, assistant pediatrics professor at Brown University's Alpert Medical School and head of the Section of Pediatric Hospitalists at Hasbro Children's Hospital, writes in a Providence Journal opinion piece.
Teenagers are irrational and make bad decisions. Or do they? A new Duke study finds that adolescents ages 10 to 16 can be more analytical in their economic choices than many slightly older young adults.
Australia's adult stem cell company, Mesoblast Limited, today announced that it had signed an agreement for production of specialised adult stem cells, known as Mesenchymal Precursor Cells (MPCs), to be used in human pilot clinical trials in patients with orthopaedic and cardiovascular diseases.
The ancient Romans studied the livers of sacrificial animals to read omens and make prophesies. Now researchers at Tokyo Medical and Dental University and Takeda-CiRA program along with a world-wide team of collaborators, have devised a polygenic risk score (PRS) based on liver genomics that can predict the likelihood of medications causing liver damage.
The rollout of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is expanding worldwide. However, little is known about the duration of protection offered by these vaccines. Real-world data on the kinetics of antibodies are beginning to appear, but a holistic picture of immunity duration is still not available.
› Verified 9 days ago
Gary Sabistina, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 599 North Lake Blvd, Tahoe City, CA 96145 Phone: 530-314-9055 |